Temozolomide

NDC 16729-050 · Accord Healthcare Inc.

Generic nameTemozolomide

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TEMOZOLOMIDE

Strength100 mg/1

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryANDA

Packages

16729-050-53 — 1 BOTTLE, GLASS in 1 CARTON (16729-050-53) / 5 CAPSULE in 1 BOTTLE, GLASS

16729-050-54 — 1 BOTTLE, GLASS in 1 CARTON (16729-050-54) / 14 CAPSULE in 1 BOTTLE, GLASS

J8700 — Temozolomide, oral, 5 mg Medicare Part B payment limit (ASP + 6%): $0.42

FDA lists these products with the same active ingredient.

0085-1519 — Temozolomide, 0085-3004 — Temozolomide, 16571-816 — temozolomide, 16571-817 — temozolomide, 16571-818 — temozolomide, 16571-819 — temozolomide, 16571-820 — temozolomide, 16571-821 — temozolomide, 16729-048 — Temozolomide, 16729-049 — Temozolomide, 16729-051 — Temozolomide, 16729-129 — Temozolomide, 16729-130 — Temozolomide, 31722-411 — TEMOZOLOMIDE, 31722-412 — TEMOZOLOMIDE, 31722-413 — TEMOZOLOMIDE, 31722-414 — TEMOZOLOMIDE, 31722-415 — TEMOZOLOMIDE, 31722-416 — TEMOZOLOMIDE, 47335-890 — Temozolomide, +50 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.